About this trial
The transition of palliative care patients from inpatient to outpatient care is aimed to be improved through structured pharmaceutical discharge management by a trained pharmacist. This data will be compared with retrospective cases.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
advanced, malignant tumour disease
advanced, chronic obstructive pulmonary disease
Patients with advanced disease and limited life expectancy (approx. 12 months) Further care in the SOPC Muenster (prospective data) Sufficient understanding of the German language to be able to understand the information and consent form
Disqualifiers
None
Trial design
Parallel
Treatments tested in this trial
Structured pharmaceutical discharge management
Other interventionThese patients will receive structured pharmaceutical discharge management from inpatient to outpatient care.
Treatment groups
Trial outcomes
Primary outcomes
(I) Drug-related problems
(I) Number of drug-related problems at the time of discharge according to PCNE (comparison of prospective, actually proposed changes vs. hypothetical number and type of problems at the time of discharge in the retrospective comparison cohort)
(II) Drug-related problems
(II) Type of drug-related problems at the time of discharge according to PCNE (comparison of prospective, actually proposed changes vs. hypothetical number and type of problems at the time of discharge in the retrospective comparison cohort)
Secondary outcomes
Number of contacts
Number of contacts made by patients/relatives with SOPC within 7 days of discharge
Number of readmissions / visits
Number of readmissions and / or visits to the emergency department within 7 and 14 days after hospital discharge
Symptom burden
Change in patient symptom burden via Integrated Palliative Care Outcome. The total scores using the IPOS can range between 0 and 68 points. The higher the score, the more severe are the patient's symptoms. Scale after 3, 7 and 14 days compared to day 0 (discharge date)
(I) Medication changes
(I) Number of medication changes suggested by pharmacists according to PCNE
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
University Hospital Muenster
Lead sponsor
University Hospital Munich
Collaborator